A 15-year-old Aboriginal boy from a remote Northern Territory community has a history of confirmed rheumatic heart disease with moderate mitral regurgitation. He is clinically well and attending for secondary prophylaxis. According to Australian rheumatic heart disease guidelines, what is the recommended interval for intramuscular benzathine benzylpenicillin G injections for secondary prophylaxis?